VIDEO: i24News
Israeli Alzheimer’s Treatment Heads to Clinical Trials
Israeli biopharmaceutical company ImmunoBrain Checkpoint is behind a new technology hailed as a groundbreaking potential treatment for Alzheimer’s. Prof. Michal Schwartz says clinical trials are set to begin soon. Video
Israeli biopharmaceutical company ImmunoBrain Checkpoint is behind a new technology hailed as a groundbreaking potential treatment for Alzheimer’s. Prof. Michal Schwartz says clinical trials are set to begin soon. Video
